Now Hiring: Inspection and Quality Improvement Associate -

Now Hiring: Inspection and Quality Improvement Associate

Do you feel like your education or work experience is not being utilized? Are you a detailed-oriented person who enjoys working on a fast-paced team? Are you confident working with numbers, and excited about new technology? Have you considered a position with a dynamic, rapidly growing manufacturing company?

We are searching for a fast-learner to inspect and improve the quality of our products. Unlike traditional quality inspection jobs, this position involves a variety of types of tasks each day, with minimal repetition due to a wide range of custom products. The right person will quickly learn the needed inspection skills and be intellectually challenged by the opportunity to interact with other team members and suppliers to continuously improve our products.

We are looking for someone who:

  • Is a fast learner
  • Is very detailed oriented
  • Works well with people in a team environment
  • Works well with their hands and with tools
  • Is comfortable using computers and Microsoft Office
  • Is very comfortable working with numbers and doing basic math
  • Enjoys working with team members and suppliers to anticipate and prevent problems.

The right person will enjoy a respected position with:

  • Competitive pay with opportunity for significant pay growth and profit sharing
  • Positive, fast-paced, but comfortable work environment
  • Highly varied tasks within the day to avoid task boredom
  • Satisfaction of working with a dynamic growing company
  • Full benefits package after trial period

You must be willing and able to pass a drug screening test and background check.

Send resume and cover letter to: jobs@equilibar.com.

Calls not accepted; Recruiters not accepted

Posted: July 24, 2017

New job opening

 

 

 

 

 

 

 

Equilibar News
PUK magazine cover with stainless steel device

Journal article focuses on oligonucleotide production using pressure control with built in dampener

Oligonucleotide drugs are made up of short sections of genetic sequences and are used to target disorders in the genetic code. The first drug of this type was used in 1998 during the AIDS epidemic.  Since then, the field has accelerated rapidly and today many oligonucleotide drugs are in clinical trials, promising improvements in treatment Read More

Read More